Filed: 8/14/2024ACC: 0000899140-24-000887
📋 What this filing means
SARISSA CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $592.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$592.42M
Total AUM (reported)
53.68M
Total Shares
Allocation by class
COM$408.32M68.9%
COM CL A$106.86M18.0%
COM NEW$60.14M10.2%
SPONS ADR NEW$17.10M2.9%
Portfolio Concentration
Top 3$375.27M63.3%
4–10$217.15M36.7%
Top 3 weight
63.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 53.68M
Sole
Full voting authority
53.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
BIOGEN INC
SOLEShares643K
TypeSH
Market value$149.06M
25.16%
Sole
643K
Shared
0.00
None
0.00
INNOVIVA INC
SOLEShares7.28M
TypeSH
Market value$119.34M
20.14%
Sole
7.28M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares16.39M
TypeSH
Market value$106.86M
18.04%
Sole
16.39M
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares1.10M
TypeSH
Market value$75.70M
12.78%
Sole
1.10M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares1.11M
TypeSH
Market value$60.14M
10.15%
Sole
1.11M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares410.48K
TypeSH
Market value$56.51M
9.54%
Sole
410.48K
Shared
0.00
None
0.00
AMARIN CORP PLC
SOLEShares24.85M
TypeSH
Market value$17.10M
2.89%
Sole
24.85M
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.09M
TypeSH
Market value$6.76M
1.14%
Sole
1.09M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares618K
TypeSH
Market value$618.0K
0.10%
Sole
618K
Shared
0.00
None
0.00
REGULUS THERAPEUTICS INC
SOLEShares185.18K
TypeSH
Market value$330.6K
0.06%
Sole
185.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOGEN INCSOLE | COM | 643K | SH | $149.06M 25.16% | 643K | 0.00 | 0.00 |
INNOVIVA INCSOLE | COM | 7.28M | SH | $119.34M 20.14% | 7.28M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 16.39M | SH | $106.86M 18.04% | 16.39M | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 1.10M | SH | $75.70M 12.78% | 1.10M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 1.11M | SH | $60.14M 10.15% | 1.11M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 410.48K | SH | $56.51M 9.54% | 410.48K | 0.00 | 0.00 |
AMARIN CORP PLCSOLE | SPONS ADR NEW | 24.85M | SH | $17.10M 2.89% | 24.85M | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.09M | SH | $6.76M 1.14% | 1.09M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 618K | SH | $618.0K 0.10% | 618K | 0.00 | 0.00 |
REGULUS THERAPEUTICS INCSOLE | COM | 185.18K | SH | $330.6K 0.06% | 185.18K | 0.00 | 0.00 |